IN2012DN01846A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01846A
IN2012DN01846A IN1846DEN2012A IN2012DN01846A IN 2012DN01846 A IN2012DN01846 A IN 2012DN01846A IN 1846DEN2012 A IN1846DEN2012 A IN 1846DEN2012A IN 2012DN01846 A IN2012DN01846 A IN 2012DN01846A
Authority
IN
India
Prior art keywords
isothiozoles
eye
disclosed
treating conditions
treating
Prior art date
Application number
Inventor
Viswanath Veena
E Donello John
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of IN2012DN01846A publication Critical patent/IN2012DN01846A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed herein are isothiozoles for treating conditions of the eye.
IN1846DEN2012 2009-08-11 2010-08-10 IN2012DN01846A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23304709P 2009-08-11 2009-08-11
PCT/US2010/044946 WO2011019678A1 (en) 2009-08-11 2010-08-10 Isothiozoles for treating conditions of the eye

Publications (1)

Publication Number Publication Date
IN2012DN01846A true IN2012DN01846A (en) 2015-08-21

Family

ID=43007053

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1846DEN2012 IN2012DN01846A (en) 2009-08-11 2010-08-10

Country Status (11)

Country Link
US (1) US20110039900A1 (en)
EP (1) EP2464351A1 (en)
JP (1) JP2013501794A (en)
KR (1) KR20120081585A (en)
CN (1) CN102695505A (en)
AU (1) AU2010282698A1 (en)
BR (1) BR112012003284A8 (en)
CA (1) CA2770894A1 (en)
IN (1) IN2012DN01846A (en)
RU (1) RU2012105453A (en)
WO (1) WO2011019678A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9814702B2 (en) * 2014-09-17 2017-11-14 Panoptica, Inc. Ocular formulations for drug-delivery and protection of the anterior segment of the eye
IL251949A0 (en) 2017-04-26 2017-07-31 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Small organic molecules for use in the treatment neuroinflammatory disorders
JP7212781B2 (en) 2018-12-19 2023-01-25 ディスアーム セラピューティクス， インコーポレイテッド Inhibitors of SARM1 in combination with neuroprotective agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US6114355A (en) * 1993-03-01 2000-09-05 D'amato; Robert Methods and compositions for inhibition of angiogenesis
US6989451B2 (en) * 2002-06-04 2006-01-24 Valeant Research & Development Heterocyclic compounds and uses thereof
SI1802579T1 (en) * 2004-10-20 2014-03-31 Merck Serono Sa Derivatives of 3-arylaminopyridine
CA2657480A1 (en) * 2006-07-25 2008-01-31 Alcon Research, Ltd. Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders

Also Published As

Publication number Publication date
WO2011019678A1 (en) 2011-02-17
US20110039900A1 (en) 2011-02-17
AU2010282698A1 (en) 2012-03-15
CN102695505A (en) 2012-09-26
JP2013501794A (en) 2013-01-17
KR20120081585A (en) 2012-07-19
BR112012003284A8 (en) 2016-05-17
CA2770894A1 (en) 2011-02-17
EP2464351A1 (en) 2012-06-20
BR112012003284A2 (en) 2016-03-01
RU2012105453A (en) 2013-09-20

Similar Documents

Publication Publication Date Title
MY184101A (en) Indoles
GB201103062D0 (en) Method
MX350661B (en) Yeast-brachyury immunotherapeutic compositions.
MX359327B (en) Methods and compositions for treating huntington's disease.
IN2011KN03851A (en)
MX2011007572A (en) Reusable outer covers for wearable absorbent articles.
MX344786B (en) Compositions and methods for treating gaucher disease.
MX2011007930A (en) Crystalline insulin-conjugates.
EA201171367A1 (en) VINYLINDASOLYL COMPOUNDS
IN2012DN04748A (en)
MX359769B (en) Methods of decellularizing bone.
JO3755B1 (en) Testosterone formulations
IN2012DN04414A (en)
IL216084A0 (en) 2,4-diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
IL213761A0 (en) Novel ortho-aminoamides for the treatment of cancer
GB2498325A (en) Modulation neural pathways
WO2011047091A9 (en) Methods for treating traumatic brain injury
GB2482817A (en) Novel use
EP4023243A3 (en) Compositions and methods for treating celiac sprue disease
IN2011KN03928A (en)
IN2014DN00254A (en)
IN2012DN04412A (en)
MX2012010443A (en) Process for the preparation of 5-substituted 1-alkyltetrazoles.
IN2012DN01846A (en)
MX2011010046A (en) Diaminopteridine derivatives.